Chordin-like 1(CHRDL1), as a secreted antagonist of BMP signaling, has been previously reported to predominantly suppress BMP4-induced migration and invasion, and its higher expression indicates better clinical outcomes in breast cancer (35). This evidence concerns the gene CHRDL1 and breast cancer.